| 利用者成果(英) |
|
20595
Matsushige T, Sakabe T, Umekita Y.
Investigation of the Subcellular Localization-Dependent Anti- or Pro-Tumor Functions of Maspin in Human Lung Adenocarcinoma Cell Line.
Yonago Acta Med
2022
65(1):44-52
PubMed ID: 35221759
DOI: 10.33160/yam.2022.02.006
|
|
13332
Hase H, Aoki M, Matsumoto K, Nakai S, Nagata T, Takeda A, Ueda K, Minami K, Kitae K, Jingushi K, Ueda Y, Yamamoto M, Furukawa T, Sato M, Tsujikawa K.
Cancer type‑SLCO1B3 promotes epithelial‑mesenchymal transition resulting in the tumour progression of non‑small cell lung cancer.
Oncol Rep
2021
PubMed ID: 33155667
DOI: 10.3892/or.2020.7839
|
|
20304
Nakasone S, Suzuki A, Okazaki H, Onodera K, Zenkoh J, Ishii G, Suzuki Y, Tsuboi M, Tsuchihara K.
Predictive markers based on transcriptome modules for vinorelbine-based adjuvant chemotherapy for lung adenocarcinoma patients.
Lung Cancer
2021
158:115-125
PubMed ID: 34157583
DOI: 10.1016/j.lungcan.2021.06.011
|
|
13773
Saigusa D, Motoike IN, Saito S, Zorzi M, Aoki Y, Kitamura H, Suzuki M, Katsuoka F, Ishii H, Kinoshita K, Motohashi H, Yamamoto M.
Impacts of NRF2 activation in non-small-cell lung cancer cell lines on extracellular metabolites
Cancer Sci
2020
111(2):667-678
PubMed ID: 31828882
DOI: 10.1111/cas.14278
|
|
11336
Kosibaty Z, Murata Y, Minami Y, Dai T, Kano J, Matsuoka R, Nakano N, Noguchi M.
Cytoplasmic expression of epithelial cell transforming sequence 2 in lung adenocarcinoma and its implications for malignant progression.
Lab. Invest.
2019
PubMed ID: 30542068
DOI: 10.1038/s41374-018-0142-4
|
|
11379
Omoto K, Matsuda R, Nakai Y, Tatsumi Y, Nakazawa T, Tanaka Y, Shida Y, Murakami T, Nishimura F, Nakagawa I, Motoyama Y, Nakamura M, Fujimoto K, Hiroyuki N.
Expression of peptide transporter 1 has a positive correlation in protoporphyrin IX accumulation induced by 5-aminolevulinic acid with photodynamic detection of non-small cell lung cancer and metastatic brain tumor specimens originating from non-small cell lung cancer.
Photodiagnosis Photodyn Ther
2019
PubMed ID: 30639584
DOI: 10.1016/j.pdpdt.2019.01.009
|
|
14822
Hayashi T, Desmeules P, Smith RS, Drilon A, Somwar R, Ladanyi M.
RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition
Clin Cancer Res
2018
24(6):1436-1447
PubMed ID: 29127119
DOI: 10.1158/1078-0432.CCR-17-2343
|
|
7050
Kajiura K, Masuda K, Naruto T, Kohmoto T, Watabnabe M, Tsuboi M, Takizawa H, Kondo K, Tangoku A, Imoto I.
Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
Oncotarget
2017
8:2890-2905
PubMed ID: 27926516
DOI: 10.18632/oncotarget.13761
|
|
10280
Seike M, Kim CH, Zou F, Noro R, Chiba M, Ishikawa A, Κunugi S, Kubota K, Gemma A.
AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
Oncol. Rep.
2017
37:3261-3269
PubMed ID: 28440492
DOI: 10.3892/or.2017.5594
|
|
10922
Shigeaki Umeda et al
Loss of IL-24 expression facilitates invasion in lung adenocarcinoma
Int J Clin Exp Pathol
2017
10:173-185
|
|
14355
Okita R, Maeda A, Shimizu K, Nojima Y, Saisho S, Nakata M.
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer
Cancer Immunol Immunother
2017
66(7):865-876
PubMed ID: 28341875
DOI: 10.1007/s00262-017-1986-y
|
|
9522
Nishijima N, Seike M, Soeno C, Chiba M, Miyanaga A, Noro R, Sugano T, Matsumoto M, Kubota K, Gemma A.
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells.
Int. J. Oncol.
2016
48:937-44
PubMed ID: 26783187
DOI: 10.3892/ijo.2016.3331
|
|
12967
Okita R, Yukawa T, Nojima Y, Maeda A, Saisho S, Shimizu K, Nakata M.
MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer
Cancer Immunol Immunother
2016
65(5):499-509.
PubMed ID: 26940474
DOI: 10.1007/s00262-016-1814-9
|
|
13810
Chen S, Huang L, Sun K, Wu D, Li M, Li M, Zhong B, Chen M, Zhang S.
Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis
PLoS One
2015
10(5):e0125480
PubMed ID: 25974088
DOI: 10.1371/journal.pone.0125480
|
|
14314
Okita R, Wolf D, Yasuda K, Maeda A, Yukawa T, Saisho S, Shimizu K, Yamaguchi Y, Oka M, Nakayama E, Lundqvist A, Kiessling R, Seliger B, Nakata M.
Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
PLoS One
2015
10(10):e0139809
PubMed ID: 26439264
DOI: 10.1371/journal.pone.0139809
|
|
6398
Nagano K, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S
Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Biochem Biophys Res Commun
2014
450(1):545-9
PubMed ID: 24924629
DOI: 10.1016/j.bbrc.2014.06.007
|
|
13754
Narita K, Matsuda Y, Seike M, Naito Z, Gemma A, Ishiwata T.
Nestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma
Int J Oncol
2014
44(4):1118-30
PubMed ID: 24481417
DOI: 10.3892/ijo.2014.2278
|
|
15845
Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A.
MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells
Mol Cancer Ther
2014
13(2):444-53
PubMed ID: 24258346
DOI: 10.1158/1535-7163.MCT-13-0448
|
|
7714
Huqun, Ishikawa R, Zhang J, Miyazawa H, Goto Y, Shimizu Y, Hagiwara K, Koyama N.
Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer.
Cancer
2012
118:1599-606
PubMed ID: 21837672
DOI: 10.1002/cncr.26441
|
|
16490
Shiba-Ishii A, Noguchi M.
Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma
Am J Pathol
2012
180(4):1653-62
PubMed ID: 22310466
DOI: 10.1016/j.ajpath.2011.12.014
|
|
16538
Shimomura M, Yaoi T, Itoh K, Kato D, Terauchi K, Shimada J, Fushiki S.
Drug resistance to paclitaxel is not only associated with ABCB1 mRNA expression but also with drug accumulation in intracellular compartments in human lung cancer cell lines
Int J Oncol
2012
40(4):995-1004
PubMed ID: 22179563
DOI: 10.3892/ijo.2011.1297
|
|
16488
Shiba-Ishii A, Kano J, Morishita Y, Sato Y, Minami Y, Noguchi M.
High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma
Int J Cancer
2011
129(10):2445-53
PubMed ID: 21207417
DOI: 10.1002/ijc.25907
|
|
5870
Takahashi N, Fukushima T, Yorita K, Tanaka H, Chijiiwa K, Kataoka H.
Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth.
Int J Cancer.
2010
126(7):1611-20
PubMed ID: 19711349
DOI: 10.1002/ijc.24865
|
|
15847
Mizutani H, Okano T, Minegishi Y, Matsuda K, Sudoh J, Kitamura K, Noro R, Soeno C, Yoshimura A, Seike M, Gemma A.
HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner
Oncol Lett
2010
1(6):1011-1016
PubMed ID: 22870103
DOI: 10.3892/ol.2010.190
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
13878
Tanaka Y, Goto K, Matsumoto Y, Ueoka R.
Remarkably high inhibitory effects of docosahexaenoic acid incorporated into hybrid liposomes on the growth of tumor cells along with apoptosis
Int J Pharm
2008
359(1-2):264-71
PubMed ID: 18511224
DOI: 10.1016/j.ijpharm.2008.03.045
|
|
16576
Maekawa S, Iwasaki A, Shirakusa T, Kawakami T, Yanagisawa J, Tanaka T, Shibaguchi H, Kinugasa T, Kuroki M, Kuroki M.
Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma
Oncol Rep
2008
19(6):1461-8
PubMed ID: 18497951
|
|
17238
Matsuda Y, Yamamoto T, Kudo M, Kawahara K, Kawamoto M, Nakajima Y, Koizumi K, Nakazawa N, Ishiwata T, Naito Z.
Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma
Int J Oncol
2008
33(6):1177-85
PubMed ID: 19020750
|
|
3061
Nagai, Yoshiaki, Miyazawa, Hitoshi, Tanaka, Tomoaki, Udagawa, Kiyoshi, Kato, Motoyasu, Fukuyama, Shunichiro, Yokote, Akemi, Kobayashi, Kunihiko, Kanazawa, Minoru, Hagiwara, Koichi, Hagiwara K
Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.
Cancer Res
2005
65:7276-82
PubMed ID: 16105816
DOI: 10.1158/0008-5472.CAN-05-0331
|
|
13836
Murai Y, Hayashi S, Takahashi H, Tsuneyama K, Takano Y.
Correlation between DNA alterations and p53 and p16 protein expression in cancer cell lines
Pathol Res Pract
2005
201(2):109-15
PubMed ID: 15901131
DOI: 10.1016/j.prp.2005.01.002
|
|
16489
Seike M, Kondo T, Fujii K, Okano T, Yamada T, Matsuno Y, Gemma A, Kudoh S, Hirohashi S.
Proteomic signatures for histological types of lung cancer
Proteomics
2005
5(11):2939-48
PubMed ID: 15996008
DOI: 10.1002/pmic.200401166
|
|
3338
Seike, Masahiro, Kondo, Tadashi, Fujii, Kazuyasu, Yamada, Tesshi, Gemma, Akihiko, Kudoh, Shoji, Hirohashi, Setsuo
Proteomic signature of human cancer cells.
Proteomics
2004
4:2776-88
PubMed ID: 15352251
DOI: 10.1002/pmic.200300795
|
|
12847
Ishii T, Teramoto S, Matsuse T.
GSTP1 affects chemoresistance against camptothecin in human lung adenocarcinoma cells
Cancer Lett
2004
216(1):89-102
PubMed ID: 15500952
DOI: 10.1016/j.canlet.2004.05.018
|
|
16491
Nakanishi H, Suda T, Katoh M, Watanabe A, Igishi T, Kodani M, Matsumoto S, Nakamoto M, Shigeoka Y, Okabe T, Oshimura M, Shimizu E.
Loss of imprinting of PEG1/MEST in lung cancer cell lines
Oncol Rep
2004
12(6):1273-8
PubMed ID: 15547750
|
|
16486
Mase K, Iijima T, Nakamura N, Takeuchi T, Onizuka M, Mitsui T, Noguchi M.
Intrabronchial orthotopic propagation of human lung adenocarcinoma--characterizations of tumorigenicity, invasion and metastasis
Lung Cancer
2002
36(3):271-6
PubMed ID: 12009237
DOI: 10.1016/s0169-5002(02)00004-1
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト
